Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Volatile fatty acid platform - a cornerstone for the circular bioeconomy.
Velghe F, De Wilde F, Snellinx S, Farahbakhsh S, Belderbos E, Peral C, Wiedemann A, Hiessl S, Michels J, Pierrard MA, Dietrich T. Velghe F, et al. Among authors: peral c. FEMS Microbiol Lett. 2021 May 28;368(9):fnab056. doi: 10.1093/femsle/fnab056. FEMS Microbiol Lett. 2021. PMID: 34036338
Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.
Antón J, Moreno Ruzafa E, Lopez Corbeto M, Bou R, Sánchez Manubens J, Carriquí Arenas S, Calzada Hernández J, Bittermann V, Estepa Guillén C, Mosquera Angarita J, Rodríguez Díez L, Iglesias E, Marti Masanet M, Lopez Montesinos B, González Fernández MI, de Lossada A, Peral C, Valderrama M, Llevat N, Montoro Álvarez M, Calvo Penadés I. Antón J, et al. Among authors: peral c. J Health Econ Outcomes Res. 2023 Dec 20;10(2):141-149. doi: 10.36469/001c.85088. eCollection 2023. J Health Econ Outcomes Res. 2023. PMID: 38145114 Free PMC article.
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.
Torres A, Soriano A, Rivolo S, Remak E, Peral C, Kantecki M, Ansari W, Charbonneau C, Hammond J, Grau S, Wilcox M. Torres A, et al. Among authors: peral c. Clinicoecon Outcomes Res. 2022 Mar 18;14:149-161. doi: 10.2147/CEOR.S329494. eCollection 2022. Clinicoecon Outcomes Res. 2022. PMID: 35330907 Free PMC article.
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain.
Formiga F, García-Pavía P, Martín Sánchez FJ, Navarro-Ruiz A, Rubio-Terrés C, Peral C, Tarilonte P, López-Ibáñez de Aldecoa A, Rubio-Rodríguez D. Formiga F, et al. Among authors: peral c. Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):1127-1133. doi: 10.1080/14737167.2021.1933948. Epub 2021 Jun 11. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 34047214 Free article.
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain.
Galan L, Gonzalez-Moreno J, Martínez-Sesmero JM, Muñoz-Beamud F, Santos-Rubio MD, Tran D, Lebeau P, Stewart M, Mallaina P, Tarilonte P, Peral C, Rozenbaum MH. Galan L, et al. Among authors: peral c. Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):967-973. doi: 10.1080/14737167.2021.1900738. Epub 2021 Mar 24. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 33724140 Free article.
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain.
Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MÁ, Menchén L. Taxonera C, et al. Among authors: peral c. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):73-83. doi: 10.1080/14737167.2021.1880324. Epub 2021 Feb 20. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 33615953
26 results